Wooridul Pharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wooridul Pharmaceutical Limited with three other
companies in this sector in South Korea:
JW Shinyak Corp
sales of 76.84 billion Korean Won [US$68.24 million]
Dongsung Pharmaceutical Company Limited
(82.39 billion Korean Won [US$73.16 million]
of which 92%
was Pharmaceutical Segment), and
Binex Company Ltd
(78.03 billion Korean Won [US$69.29 million]
of which 83%
During the year ended December of 2017, sales at
Wooridul Pharmaceutical Limited were 79.89 billion Korean Won (US$70.95 million).
increase of 11.7%
versus 2016, when the company's sales were 71.55 billion Korean Won.
This was the fifth consecutive year of sales increases at Wooridul Pharmaceutical Limited
(and since 2012, sales have increased a total of 164%).